High Percentage of IMP Supply Issues


High Percentage of IMP Supply Issues Table

High Percentage of IMP Supply Issues

Type of indicator Risk
Risk Category IMP supply chain
Golden KRI NO
Therapeutic Area General
IF Risk-Event The investigational product supply is impaired
DUE TO Risk Causes A warehouse, customs or shipping company problem
THEN Risk Impact MAY RESULT An interruption of the study or a delay in the study completion
Risk Indicator High Percentage of IMP Supply Issues
Metric Percent of Sites with IMP Supply Issues
Unit %
What level should be measured Study, Country
Purpose Minimize the occurrence and impact of IMP supply issues on the study's timeline, data quality, and Subject welfare.
Description Monitors the proportion of supply issues related to Investigational Medicinal Products, enabling proactive management and mitigation of risks in clinical trials or research studies.
Formula Calculate sites that faced IMP Supply issues (non-availability within XXX days) within the latest YYY days. Divide the number of sites with IMP supply issues by the total number of sites and multiply by 100%.
Suggested Thresholds - High >4 %
Suggested Thresholds - Medium >2 %
Associated Metric 1 Number of Sites
Associated Metric 2 Number of Sites with IMP Supply issues
Do you like the KRI description? Thanks for the feedback There was a problem submitting your feedback. Please try again later.